Domain interactions between coregulator ARA70 and the androgen receptor (AR)

Molecular Endocrinology

Volumn 16, Issue 2, 2002, Pages 287-300

  Zhou, Zhong Xun ^a   He, Bin ^a   Hall, Susan H ^a   Wilson, Elizabeth M ^a   French, Frank S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; GLUTATHIONE TRANSFERASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ARA70; UNCLASSIFIED DRUG;

AMINO ACID COMPOSITION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DELETION MUTANT; GENETIC TRANSCRIPTION; HORMONE DEPENDENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION;

ANIMALIA; MOUSE MAMMARY TUMOR VIRUS;

EID: 0036168790     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.16.2.0765     Document Type: Article

References (94)

1. The androgen receptor: An overview
2. Regulation of androgen action
3. Androgen receptor defects: Historical, clinical, and molecular perspectives
4. Molecular basis of androgen insensitivity
5. Human androgen insensitivity syndrome
6. Genetic basis of endocrine disease 4. The spectrum of mutations in the androgen receptor gene that causes androgen resistance
7. The steroid and thyroid hormone receptor superfamily
8. Gene regulation by steroid hormones
9. A decade of molecular biology of retinoic acid receptors
10. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
11. Transcription activation by oestrogen and progesterone receptors
12. The nuclear receptor superfamily: The second decade
13. Anatomy of the steroid receptor zinc finger region
14. Structural determinants of DNA-binding specificity by steroid receptors
15. The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: How receptors discriminate between their response elements
16. A structural role for hormone in the thyroid hormone receptor
17. A canonical structure for the ligand-binding domain of nuclear receptors
18. Atomic structure of progesterone complexed with its receptor
19. Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations
20. Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone
21. The human androgen receptor: Complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate
22. Stimulation of the activation function AF-1 of RARα through binding to the general transcription factor THIIF and phosphorylation by CDK7
23. Interaction of steroid hormone receptors with the transcription initiation complex
24. Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II)
25. Nuclear receptor coactivators and corepressors
26. The coregulator exchange in transcriptional functions of nuclear receptors
27. Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF
28. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
29. The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors
30. The transcriptional coactivator p/CIP binds CBP and mediates nuclear-receptor function
31. Nuclear receptor coregulators: Cellular and molecular biology
32. TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors
33. GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors
34. RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2
35. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300
36. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer
37. A CBP integrator complex mediates transcrip-tional activation and Ap-1 inhibition by nuclear receptors
38. TRAM-1, a novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1
39. Thyroid receptor activator molecule. TRAM-1, is an androgen receptor coactivator
40. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α
41. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid
42. A signature motif in transcriptional co-activators mediates binding to nuclear receptors
43. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18
44. Multiple receptor interaction domains of GRIP1 function in synergy
45. The structure basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
46. Structure and specificity of nuclear receptor-coactivator interactions
47. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
48. The CBP coactivator is a histone acetyltransferase
49. The transcription coactivators p300 and CBP are histone acetyltransferase
50. Increasing the complexity of coactivation in nuclear receptor signaling
51. Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex
52. The TAFs in the HAT
53. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells
54. RFG (ARA70, ELE1) interacts with the human androgen receptor in a ligand dependent fashion but functions only weakly as a coactivator in cotransfection assays
55. 70/ELE1α with multiple steroid receptors and identification of an internally deleted ELE1β isoform
56. The presence of a transcription activation function in the hormone-binding domain of androgen receptor is revealed by studies in yeast cells
57. Molecular characterization of RET/PTC3; a novel rear-ranged version of the RET proto-oncogene in a human thyroid papillary carcinoma
58. 2-terminal interaction with the ligand binding domain of the androgen receptor
59. 2-terminal domain
60. Protein inhibitor of activated STAT-1 is a nuclear receptor co-regulator expressed in human testis
61. Estrogen and spermatogenesis
62. From estrogen to androgen receptor: A new pathway for sex hormones in prostate
63. Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor-γ
64. Transcriptional activation and nuclear targeting signals of the human androgen receptor
65. Delineation of two distinct type 1 activation functions in the androgen receptor amino-terminal domain
66. Identification of two transcription activation units in the N-terminal domain of the human androgen receptor
67. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators
68. 2-terminal and steroid-binding domains
69. Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer
70. 2-/carboxyl-terminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensitivity
71. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor
72. 2- and COOH-terminal interaction inhibits p160 coactivator recruitment by activation function 2
73. The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription
74. Multiple signal input and output domains of the 160-kilodalton nuclear receptor coactivator proteins
75. The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1
76. Estrogen receptor activation function 1 works by binding p160 coactivator proteins
77. Ligand-independent recruitment of SRC-1 to estrogen receptor β through phosphorylation of activation function AF-1
78. Identification of three proline-directed phosphorylation sites in the human androgen receptor
79. Forskolin-induced dephosphorylation of the androgen receptor impairs ligand binding
80. Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor
81. Inhibition of Stat1-mediated gene activation by PIAS1
82. A testis-specific androgen receptor coregulator that belongs to a novel family of nuclear proteins
83. Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription
84. Activation of androgen receptor function by a novel nuclear protein kinase
85. Identification of a new family of tissue-specific basic helix-loop-helix proteins with a two-hybrid system
86. A general method of in vitro preparation and specific mutagenesis of DNA fragments: Study of protein and DNA interactions
87. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product
88. A versatile in vivo and in vitro eukaryotic expression vector for protein engineering
89. Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system
90. Protein-protein interactions in the yeast pheromone response pathway: Ste5p interacts with all members of the MAP kinase cascade
91. The rat androgen receptor: Primary structure, autoregulation of its messenger ribonucleic acid, and immunocytochemical localization of the receptor protein
92. 2-terminal and carboxyl-terminal sequences
93. Apparent coactivation due to interference of expression constructs with nuclear receptor expression
94. Expression of recombinant androgen receptor in cultured mammalian cells